PERTH, Australia, Aug. 8, 2019 /PRNewswire/ -- Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), announced today that it has adopted artificial intelligence (AI) applications into its radiology workflow, and is one of the first diagnostic imaging companies in Australia to do so. GDA has partner

LAKE FOREST, Calif., Aug. 7, 2019 /PRNewswire/ -- InMode Ltd. ("InMode"), announced today the pricing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The underwriters of the offering will also have a 30-day option to purchase up to an additional 750,000 ordina

SHANGHAI, Aug. 7, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced its winning of the 2019 China Healthcare Industry Best Company Award at the 4th China Healthcare Industry Summit held in

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Novartis AG ("Novartis") (NYSE: NVS) for violations of federal securities laws. On August 7, 2019, Novartis made known that it knew about discrepancies in data it submitted to regulators as it sought appro

- Irritable Bowel Syndrome Safety Update at 36 months (IBSSU36) reconfirms the excellent safety and tolerability profile of IBgard® previously seen at 24 months1- No pattern of  heartburn was seen with IBgard, which clearly separates it from conventional peppermint oil products2, §§

BALDWIN PARK, Calif., Aug. 7, 2019 /PRNewswire/ -- California-based StemCyte, Inc., the pioneer in newborn stem cell therapy, is proud to announce the strategic partnership renewal with Sharp HealthCare, which includes Sharp Mary Birch Hospital for Women & Newborns. It is the largest and most extensive freestanding center for women's health in

SAN FRANCISCO, Aug. 7, 2019 /PRNewswire/ -- Quantum Leap Healthcare Collaborative (QLHC) joins Merck in acknowledging the promising data from the KEYNOTE-522 trial. Merck recently announced that the Phase 3 KEYNOTE-522 trial met a primary endpoint, demonstrating statistically significant improved rates of pathological complete response for KEYTRUDA® (pembrolizumab), 

DUBLIN, Ohio, Aug. 7, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that Dean Scarborough, former Chairman and Chief Executive Officer of Avery Dennison Corporation, and John Weiland, former Vice Chairman, President and Chief Operating Officer of C.R. Bard, Inc., will join its Board of Directors effective

DUBLIN, Aug. 7, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of "Quality Affordable Self-Care Products™", today announced that Jeffrey C. Smith, Managing Member, Chief Executive Officer, and Chief Investment Officer of Starboard Value LP, who has been a director since 2017, has re

LOUISVILLE, Ky., Aug. 7, 2019 /PRNewswire/ -- Galen College of Nursing announced today the construction of a new Louisville Campus at Terra Crossing Boulevard, off the Old Henry exit at the Gene Snyder Freeway. The new campus, which will house both the Louisville Campus and the College's national administrative headquarters, will be complete winter of 2020.